These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21434725)

  • 1. [Parkinsonism due to clebopride].
    Berriozabal Diaz L; Zubiaurre Lizarralde L; Castiella Eguzkiza A; Zapata Morcillo E
    Rev Esp Enferm Dig; 2011 Mar; 103(3):161-2. PubMed ID: 21434725
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism and tardive dyskinesia after chronic use of clebopride.
    Sempere AP; Duarte J; Palomares JM; Coria F; Clavería LE
    Mov Disord; 1994 Jan; 9(1):114-5. PubMed ID: 8166880
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonian syndrome after long-term treatment with clebopride.
    Montagna P; Gabellini AS; Monari L; Lugaresi E
    Mov Disord; 1992; 7(1):89-90. PubMed ID: 1557073
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of clebopride in functional dyspepsia.
    Del Favero G; Di Mario F; Meggiato T; Scalon P; Mastropaolo G; Martin A
    Ital J Gastroenterol; 1991; 23(6):393. PubMed ID: 1742535
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying.
    Bavestrello L; Caimi L; Barbera A
    Clin Ther; 1985; 7(4):468-73. PubMed ID: 3893703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute oculogyric crisis in a patient taking clebopride.
    Kim W; Lee KS; Kim YI; Kim JS
    Intern Med; 2008; 47(6):551-2. PubMed ID: 18344644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemi-restless legs syndrome induced by clebopride.
    Erro R; Amboni M; Allocca R; Santangelo G; Barone P; Vitale C
    Eur J Neurol; 2012 Jun; 19(6):e59. PubMed ID: 22577755
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I-trial of clebopride, a new antiemetic, in chemotherapy--induced nausea and vomiting.
    Lenz HJ; Schuler U; Hicking W; Ehninger G
    Eur J Clin Pharmacol; 1990; 38(5):525. PubMed ID: 2379541
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute hemifacial dystonia possibly induced by clebopride.
    Bosco D; Plastino M; Marcello MG; Mungari P; Fava A
    Clin Neuropharmacol; 2009; 32(2):107-8. PubMed ID: 19512962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent parkinsonism and tardive dyskinesia induced by clebopride.
    Jiménez-Jiménez FJ; Cabrera-Valdivia F; Ayuso-Peralta L; Tejeiro J; Vaquero A; García-Albea E
    Mov Disord; 1993 Apr; 8(2):246-7. PubMed ID: 8474508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy and diagnosis of patients with drug-induced parkinsonism].
    Yamamoto T
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1467-71. PubMed ID: 13677896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rabbit syndrome due to clebopride].
    Ortín Castaño A; Otero MJ; Martín Polo J
    Med Clin (Barc); 2003 Jun; 121(1):38-9. PubMed ID: 12812712
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clebopride and the extrapyramidal syndrome].
    Sanz Amaro A
    An Esp Pediatr; 1987 Dec; 27(6):485. PubMed ID: 3447504
    [No Abstract]   [Full Text] [Related]  

  • 16. [An extrapyramidal syndrome due to clebopride].
    Serrano Serrano ME; Alvarez Frejo M; Tabernero García J; Martín Martín S
    Aten Primaria; 1999 Jan; 23(1):50-1. PubMed ID: 10079564
    [No Abstract]   [Full Text] [Related]  

  • 17. Transient dyskinesia induced by clebopride.
    Martínez-Martín P
    Mov Disord; 1993; 8(1):125-6. PubMed ID: 8419802
    [No Abstract]   [Full Text] [Related]  

  • 18. An estimate of the risk of movement disorders associated with the chronic use of clebopride.
    Sempere AP; Duarte J; García F; Cabezas C; Coria F; Clavería LE
    Mov Disord; 1996 Sep; 11(5):582-3. PubMed ID: 8866504
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive supranuclear palsy syndrome induced by clebopride.
    Campdelacreu J; Kumru H; Tolosa E; Valls-Solé J; Benabarre A
    Mov Disord; 2004 Apr; 19(4):482-4. PubMed ID: 15077251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tardive dystonia following the administration of clebopride].
    Sempere AP; Mola S; Flores J
    Rev Neurol; 1997 Dec; 25(148):2060. PubMed ID: 9528065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.